OTCMKTS:DGNOF

DIAGNOS - DGNOF Stock Forecast, Price & News

$0.27

+0.01 (+2.76%)

(As of 03/22/2023)

Add

Compare

Today's Range: $0.27
▼
$0.27
50-Day Range: $0.22
▼
$0.32
52-Week Range: $0.11
▼
$0.32

Volume: 7,500 shs
Average Volume: 6,705 shs
Market Capitalization: $19.17 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About DIAGNOS (OTCMKTS:DGNOF) Stock

Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company offers algorithm development, data analysis, and image processing services. It focuses on the development of its AI tool, Computer Assisted Retina Analysis, which is a tele-ophthalmology platform that integrates with existing equipment and processes at the point of care. The company was founded by Djamel Abdelkader Zighed in 1998 and is headquartered in Brossard, Canada.

Receive DGNOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

DGNOF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

30 days | 90 days | 365 days | Advanced Chart

Receive DGNOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

DGNOF Company Calendar

Today: 3/26/2023
Fiscal Year End: 3/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Private households
Sub-Industry: N/A
Sector: Business Services
Current Symbol: OTCMKTS:DGNOF
CUSIP: N/A
CIK: N/A
Web: www.diagnos.ca
Phone: (450) 678-8882
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-2,080,000.00
Net Margins: -445.58%
Pretax Margin: -445.35%
Return on Equity: -30,389.99%
Return on Assets: -235.56%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.81
Quick Ratio: 0.81

Sales & Book Value

Annual Sales: $350,000.00
Price / Sales: 54.77
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 70,610,000
Free Float: N/A
Market Cap: $19.17 million
Optionable: Not Optionable
Beta: 0.66

Key Executives

André M. Larente
President, Chief Executive Officer & Director

Marc-André Massue
Chief Financial Officer, Secretary & VP-Finance

Riadh Kobbi
Vice President-Business Intelligence

Guillermo Moreno Robles
Vice President-Sales

Yves-Stéphane Couture
Vice President-Sales

Key Competitors

View All Competitors

DGNOF Stock - Frequently Asked Questions

How have DGNOF shares performed in 2023?: DIAGNOS's stock was trading at $0.2156 at the beginning of 2023. Since then, DGNOF shares have increased by 26.0% and is now trading at $0.2715.
View the best growth stocks for 2023 here.
Are investors shorting DIAGNOS?: DIAGNOS saw a drop in short interest in the month of February. As of February 15th, there was short interest totaling 500 shares, a drop of 95.8% from the January 31st total of 11,900 shares. Based on an average trading volume of 7,800 shares, the short-interest ratio is presently 0.1 days.
View DIAGNOS's Short Interest.
What is DIAGNOS's stock symbol?: DIAGNOS trades on the OTCMKTS under the ticker symbol "DGNOF."

How do I buy shares of DIAGNOS?: Shares of DGNOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is DIAGNOS's stock price today?: One share of DGNOF stock can currently be purchased for approximately $0.27.
How much money does DIAGNOS make?: DIAGNOS (OTCMKTS:DGNOF) has a market capitalization of $19.17 million and generates $350,000.00 in revenue each year. The company earns $-2,080,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.
How can I contact DIAGNOS?: DIAGNOS's mailing address is 7005 Taschereau Boulevard Suite 340, Brossard A8, J4Z 1A7. The official website for the company is www.diagnos.ca. The company can be reached via phone at (450) 678-8882.

This page (OTCMKTS:DGNOF) was last updated on 3/27/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial